A comparison of the reactivating and therapeutic efficacy of newly developed bispyridinium oximes (K250, K251) with commonly used oximes against tabun in rats and mice.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples